HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Retinol Derivative Treats Photodamaged Skin Without Side Effects – Study

This article was originally published in The Rose Sheet

Executive Summary

Retinol derivative retinyl N-formyl aspartamate was found to be "significantly" more effective than a placebo in treating photodamaged skin in a study published in the August issue of the Journal of the American Academy of Dermatology

You may also be interested in...



L’Oréal Anti-Aging Molecule Reinforces Skin Matrix – Researcher

L'Oréal has developed a new anti-aging molecule called pro-xylane, which reinforces the extracellular matrix of skin, according to L'Oréal Senior VP Research and Development Alan Meyers

CIR Reopens N-Butyl Alcohol Review To Address Non-Nail Uses

The Cosmetic Ingredient Review Expert Panel is reopening its safety assessment of n-butyl alcohol to create a tentative addendum incorporating the use of the substance in non-nail care formulas, the panel announced during a June 13-14 meeting in Washington, D.C

P&G Restores Volume Growth In Beauty, Grooming After Pricing Run

Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel